Invests in
Locations:
Min Investment:
$10,000,000.00Max Investment:
$50,000,000.00Target Investment:
$25,000,000.00
Skills
Education
- SU
- MI
Lists including Naveen
Investments
Work Experience
2015
Partner
2015
Portfolio manager at RTW - $6.5b AUM healthcare investment firm. www.RTWfunds.com
Dean's Leadership Council
2025
Council Member
2025
2019
Board Observer
2019
Board Observer
2018
2015 - 2025
Co-Founder and Board Director
2015 - 2025
A clinical stage gene therapy company. Lead indications include: Danon Disease, Fanconi Anemia, Pyruvate Kinase Deficiency. (NASDAQ: RCKT) www.rocketpharma.com
2023 - 2024
Board Observer
2023 - 2024
2020 - 2023
Chief Financial Officer
2020 - 2023
Health Sciences Acquisitions Corporation 2 (NASDAQ: HSAQ) completed a business combination with Orchestra Biomed (NASDAQ:OBIO) in Jan 2023.
2019 - 2019
Chief Financial Officer
2019 - 2019
Health Sciences Acquisitions Corporation (NASDAQ: HSAC) merged with Immunovant Ltd on December 18, 2019. The combined entity is "Immunovant, Inc" (NASDAQ: IMVT).
2017 - 2019
Board Observer
2017 - 2019